Emerging resistance to artemisinin means efforts to track genetic markers and regulate the drug's use must step up, says Priya Shetty.

Improving health for the poor depends on nurturing local innovations — and learning how to deliver them, argue Abdallah Daar and Peter Singer.

Much progress has been made in genomics research, says Stephen Baker, but the impact on public health is limited in the developing world.

Health systems in developing nations aren't ready for the diseases that accompany ageing, writes Priya Shetty.

Healthcare policies and research strategies in developing countries must adapt to the new big killers, says Priya Shetty.

Developing world scientists should be empowered to do their own medical genomics research, say Carlos D. Bustamante and colleagues.

After recent gains against trypanosomiasis, new diagnostic and treatment tools mean we can make the final push, says Priya Shetty.

Vietnam is making rapid progress in developing biotechnology for a healthier society, says biotech expert Thai Nguyen.

Livestock genebanks are needed to ensure the world's future food supply, says livestock expert Carlos Seré.

Jim Kaput explains why efforts to tackle malnutrition should consider nutrigenomics — the interplay between food and genetic make-up.

Poor countries need support to participate in genomics research, say Josefina Coloma and Eva Harris in PLoS Medicine.

Translating genetics research is easier in agriculture than medicine, says a Nature Genetics editorial, and existing technologies can be used.

Tewolde Egziabher and other SciDev.Net readers join the debate on the relevance of the UN biodiversity convention's Cartagena Protocol on genetically modified organisms.

Peter Raven and colleagues argue that it is time to sequence the genome of cassava, a crop vital to the health and livelihoods of half a billion people.

David Weatherall says that pharmacogenetics — or tailor-made medicine — could be the future, but needs to be evaluated carefully before we depart from traditional diagnostic techniques.

Wilmot James argues that South Africa could take part in high-level biological research — as long its government provides promised funding.